Waters Corporation Stock Price: Quote, Financials, Forecast & News (WAT)

Waters Corporation

WAT · NYSE

$400.98+$4.901.24%

As of: Aug 5, 6:10 PM

Prev Close: $396.08
Market Cap: $39.37B
Open: —
Trailing P/E: —
Day Range: $402.30 - $390.75
52W Range: $414.15 - $275.05
Forward P/E: —
EPS: —
Volume: 482.43K
Dividend Yield: —

Notable Price Movement

Aug 3-7$396.084.97%
Waters rose $12.18, or 3.17%, from $383.90 to $396.08, despite weakening through the first four sessions. The stock fell from $383.90 on July 28 to $374.74 on August 3, including a 1.67% decline on August 3 on volume of 1.16 million shares, then reversed sharply on August 4, gaining 5.69% on nearly 2.0 million shares. The late-week advance followed the company’s second-quarter update, which showed earnings and revenue beats of 1.33% and 1.25% and included higher 2026 guidance. The reported $136 million GAAP loss and $1.39 loss per share were material offsets, but investors appeared to prioritize the raised outlook and quarterly beats.

Stories & Analysis

Waters (WAT) Q2 Earnings and Revenues Beat Estimates

Zacks · 1d ago

Waters Posts Loss In Q2; Raises 2026 Guidance

RTTNews · 1d ago

Waters (WAT) Earnings Expected to Grow: Should You Buy?

Zacks · Jul 28

Will Waters (WAT) Beat Estimates Again in Its Next Earnings Report?

Zacks · Jul 27

IQVIA Gears Up to Report Q2 Earnings: What's in the Offing?

Zacks · Jul 24 S&P 500 Analyst Moves: WAT

BNK Invest · Jun 30 Waters Achieves #117 Analyst Rank, Surpassing Albemarle

BNK Invest · Jun 30 Waters Partners IMU Biosciences To Develop IMU's Next-gen AI-powered HD Immunology Platform

RTTNews · Jun 24

Symbol: WAT
Type: Stock
Sector: Industrials
Industry: Biotechnology: Laboratory Analytical Instruments
Country: North America
Exchange: NYSE

Waters Corporation (NYSE: WAT) is a global leader in life sciences and diagnostics, dedicated to accelerating the benefits of pioneering science through analytical technologies, informatics, and service. With a focus on regulated, high-volume testing environments, our innovative portfolio harnesses deep scientific expertise across chemistry, physics, and biology. We collaborate with customers around the world to advance the release of effective, high-quality medicines, ensure the safety of food and water, and drive better patient outcomes by detecting diseases earlier, managing routine infections, and combating antibiotic resistance. Through a shared culture of relentless innovation, our passionate team of ~16,000 colleagues turn scientific challenges into breakthroughs that improve lives worldwide.

Key Issues

Bullish view

Waters raised 2026 guidance, while second-quarter earnings and revenue exceeded estimates by 1.33% and 1.25%, suggesting the forward outlook remains stronger than the reported quarter.

Bearish view

The quarter included a $136 million net loss and a $1.39 GAAP loss per share, versus $147 million of net income and $2.47 EPS a year earlier, raising questions about earnings quality and near-term profitability.

Analyst Consensus

See all

Buy

17 analysts

$401

Current

—

Low

$420

Average

—

High

Average target implies +4.74% versus the current price.

Earnings History

BeatMissNo estimate

Peers

Agilent Technologies, Inc.A · NYSE$141.16